EBSCO Research | Research

Current News

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis 2022-12-21 17:00:00

Serpentine Supravenous Hyperpigmentation

Serpentine Supravenous Hyperpigmentation 2022-12-21 17:00:00

Oxygen Delivery in the Treatment of Anemia

Oxygen Delivery in the Treatment of Anemia 2022-12-21 17:00:00

Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia

Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia 2022-12-21 17:00:00

Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis

Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis 2022-12-21 17:00:00